<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00833157</url>
  </required_header>
  <id_info>
    <org_study_id>HIM-037</org_study_id>
    <secondary_id>KF-01-18904</secondary_id>
    <nct_id>NCT00833157</nct_id>
  </id_info>
  <brief_title>Effect of Glucosamine or Ibuprofen Combined With Physical Training in Patients With Knee-Osteoarthritis</brief_title>
  <official_title>Effect of Glucosamine or Ibuprofen Combined With Physical Training in Patients With Knee-Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Danish Rheumatism Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of the Interior and Health, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will investigate the effect of glucosamine or ibuprofen combined with 12
      weeks of muscle strength-training in patients with knee-osteoarthritis.

      The investigators would like to elucidate whether treatment with glucosamine or NSAID
      interact with the effects of exercise in osteoarthritis patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>February 2005</start_date>
  <completion_date type="Anticipated">March 2009</completion_date>
  <primary_completion_date type="Actual">July 2007</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>muscle strength and hypertrophy</measure>
    <time_frame>We measure before and after 12-weeks strength training.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>cartilage biomarkers</measure>
    <time_frame>We measure before and after 12 weeks strength training</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>muscle regeneration and function</measure>
    <time_frame>We measure before and after 12-weeks strength training.</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Osteoarthritis of the Knee</condition>
  <arm_group>
    <arm_group_label>Glucosamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>glucosamine sulphate</intervention_name>
    <description>Subjects are administered glucosamine-sulphate tablets of 500 mg * 3 daily, while they are performing a strength-training program with both legs (*3 weekly) for 12 weeks.</description>
    <arm_group_label>Glucosamine</arm_group_label>
    <other_name>glucosamine from Ferrosan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ibuprofen</intervention_name>
    <description>Subjects are administered 600 mg * 2 daily, while they are performing a strength-training program with both legs (*3 weekly) for 12 weeks</description>
    <arm_group_label>Ibuprofen</arm_group_label>
    <other_name>&quot;Ibumetin&quot; from Nycomed (vnr:38 83 71)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Subjects are administered placebo tablets, while they are performing a strength-training program (*3 weekly) with both legs for 12 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 50 to 70 years

          -  Bilateral tibiofemoral osteoarthritis of the knee on x-ray

          -  American College of Rheumatology (ACR) clinical classification criteria

        Exclusion Criteria:

          -  Severe health problems such as cardiovascular disease, active cancer, diabetes, kidney
             or liver diseases

          -  Excess alcohol use (&gt; 21 alcoholic drinks per week)

          -  Severe overweight (BMI &gt; 35)

          -  History of injury or operation in the knee, planned knee-joint replacement, other
             rheumatologic diseases, previous gastric ulcer, allergy to the contents of ibuprofen
             or glucosamine, regular strength training prior to the inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susanne G Petersen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg Hospital, Institute of Sports Medicine Copenhagen</affiliation>
  </overall_official>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2009</study_first_submitted>
  <study_first_submitted_qc>January 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2009</study_first_posted>
  <last_update_submitted>January 29, 2009</last_update_submitted>
  <last_update_submitted_qc>January 29, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2009</last_update_posted>
  <responsible_party>
    <name_title>Susanne G. Petersen, doctor</name_title>
    <organization>Institute of Sports Medicine Copenhagen, Bispebjerg Hospital, Denmark</organization>
  </responsible_party>
  <keyword>Knee Osteoarthritis</keyword>
  <keyword>exercise</keyword>
  <keyword>strength training</keyword>
  <keyword>Glucosamine</keyword>
  <keyword>Dietary supplement</keyword>
  <keyword>Ibuprofen</keyword>
  <keyword>NSAID</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

